AUSTIN, Texas, Jan. 6, 2025 /PRNewswire/ — Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that members from its executive leadership team will be attending and participating in investor, industry and business development meetings at the 43rd Annual J.P.… Continue reading Genprex to Participate at the 43rd Annual J.P. Morgan Healthcare Conference
Tag: Morgan
Sling Therapeutics Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
ANN ARBOR, Mich., Jan. 6, 2025 /PRNewswire/ — Sling Therapeutics, Inc., a biopharmaceutical company focused on late-stage development of an oral small molecule for the treatment of thyroid eye disease (TED), today announced that Raymond Douglas, M.D., Ph.D., Chief Scientific Officer of Sling, will present at the 43rd Annual J.P. Morgan Healthcare Conference being held… Continue reading Sling Therapeutics Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
BOSTON, Jan. 6, 2025 /PRNewswire/ — Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time. The public may access Mr. Simon’s presentation live via audio webcast at: https://jpmorgan.metameetings.net/events/healthcare25/sessions/58190-haemonetics-corporation/webcast?gpu_only=true&kiosk=true The live… Continue reading Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare Conference
Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference
SAN FRANCISCO and SUZHOU, China, Jan. 5, 2025 /PRNewswire/ — Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the company will participate in the 43rd Annual J.P. Morgan Healthcare Conference.… Continue reading Innovent to Participate and Present at the 43rd Annual J.P. Morgan Healthcare Conference
ENPH Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Enphase Energy, Inc. (ENPH) Investors that a Securities Fraud Class Action Lawsuit Has Been Filed
RADNOR, Pa., Jan. 5, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Enphase Energy, Inc. (NASDAQ: ENPH) (“Enphase” or the “Company”) on behalf of all persons and entities who purchased or otherwise acquired Enphase common stock… Continue reading ENPH Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Enphase Energy, Inc. (ENPH) Investors that a Securities Fraud Class Action Lawsuit Has Been Filed
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman
SAN FRANCISCO, Jan. 3, 2025 /PRNewswire/ — Shares of BioAge (NASDAQ: BIOA) have plummeted since the company’s December 6 announcement of the discontinuation of a Phase 2 trial for its weight-loss drug azelaprag due to safety concerns. The abrupt halt comes just a little over two months after the company raised $198 million in a highly… Continue reading BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO- Hagens Berman
ETA Announces 2025 Industry Affairs Committee Leadership
WASHINGTON, Jan. 3, 2025 /PRNewswire/ — The Electronic Transactions Association (ETA) today announced its 2025 Industry Affairs Committee leadership structure, reflecting the organization’s continued commitment to advancing the payments technology industry through expert guidance and collaboration. The committees, comprising over 700 payments professionals from more than 400 member companies and led by experienced industry executives,… Continue reading ETA Announces 2025 Industry Affairs Committee Leadership
10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
PLEASANTON, Calif., Jan. 2, 2025 /PRNewswire/ — 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, at 7:30 a.m. Pacific Time. Interested parties may access a live webcast of the fireside… Continue reading 10x Genomics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Meet the 2025 St. Baldrick’s Foundation Ambassadors
LOS ANGELES, Jan. 2, 2025 /PRNewswire/ — The St. Baldrick’s Foundation, the largest charity funder of childhood cancer research grants, is proud to introduce its 2025 Ambassadors who along with their families, will share their unique journey and experiences associated with childhood cancer. Each year, St. Baldrick’s selects five children from the 400,000 diagnosed with cancer… Continue reading Meet the 2025 St. Baldrick’s Foundation Ambassadors
Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics
Kadima Neuropsychiatry Institute in La Jolla, CA to serve as flagship for an international network of clinics dedicated to treating depression and PTSD Kadima’s founder, David Feifel, MD, PhD, Professor Emeritus of Psychiatry at University of California San Diego, a pioneer in advanced interventional treatments for neuropsychiatric conditions such as depression and PTSD, to join… Continue reading Hope Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Kadima Neuropsychiatry Institute as the Expected First Acquisition for its International Network of Interventional Psychiatry Clinics